This indicates that NT-pro-BNP could serve as a valuable prognostic indicator for ischemic stroke.[19] A study identified a correlation between NT-pro-BNP levels in stroke patients receiving intravenous thrombolysis and adverse 3-month functional outcomes and mortality in individuals undergoing intravenous thrombolysis for stroke. The gene discussed is NPPB; the disease is ischemic stroke.